Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Schlaak

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 31, 2015
Electrochemotherapy in advanced skin tumors and cutaneous metastases - a retrospective multicenter analysisAlexander Kreuter, Tina van Eijk, Percy Lehmann, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 2018
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disordersKatharina C Kähler, Thomas K Eigentler, Anja Gesierich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 22, 2026
Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapyKristine E Mayer, Jessica C Hassel, Jannik Sambale, et al.
Cancers|September 2, 2020
Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score MatchingMaike Trommer, Jaika Kinsky, Anne Adams, et al.
BMC Cancer|November 29, 2023
TIGIT<sup>+</sup> NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patientsAnastasia Tsakmaklis, Fedja Farowski, Rafael Zenner, et al.
Cancer Immunology Research|June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cellsPhilipp Müller, Kea Martin, Sebastian Theurich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 31, 2014
Effectiveness and tolerability of ipilimumab: experiences from 198 patients included in a named-patient program in various daily-practice settings and multiple institutionsThomas K Eigentler, Max Schlaak, Jessica C Hassel, et al.
Cancer Immunology Research|July 29, 2016
Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant MelanomaSebastian Theurich, Sacha I Rothschild, Michael Hoffmann, et al.
Oncotarget|October 23, 2018
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter studyJulia K Tietze, Andrea Forschner, Carmen Loquai, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2023
Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitorsSebastian Mönch, Maurice M Heimer, Michael Winkelmann, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 31, 2015
Electrochemotherapy in advanced skin tumors and cutaneous metastases - a retrospective multicenter analysisAlexander Kreuter, Tina van Eijk, Percy Lehmann, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 2018
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disordersKatharina C Kähler, Thomas K Eigentler, Anja Gesierich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 22, 2026
Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapyKristine E Mayer, Jessica C Hassel, Jannik Sambale, et al.
Cancers|September 2, 2020
Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score MatchingMaike Trommer, Jaika Kinsky, Anne Adams, et al.
BMC Cancer|November 29, 2023
TIGIT<sup>+</sup> NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patientsAnastasia Tsakmaklis, Fedja Farowski, Rafael Zenner, et al.
Cancer Immunology Research|June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cellsPhilipp Müller, Kea Martin, Sebastian Theurich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 31, 2014
Effectiveness and tolerability of ipilimumab: experiences from 198 patients included in a named-patient program in various daily-practice settings and multiple institutionsThomas K Eigentler, Max Schlaak, Jessica C Hassel, et al.
Cancer Immunology Research|July 29, 2016
Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant MelanomaSebastian Theurich, Sacha I Rothschild, Michael Hoffmann, et al.
Oncotarget|October 23, 2018
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter studyJulia K Tietze, Andrea Forschner, Carmen Loquai, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2023
Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitorsSebastian Mönch, Maurice M Heimer, Michael Winkelmann, et al.
Pageof 10